XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.24.4

FINANCIAL INSTRUMENTS | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2024 | Dec. 31, 2023
Notes and other explanatory information [abstract] |  |
FINANCIAL INSTRUMENTS |
| 14. | FINANCIAL INSTRUMENTS
(a) |  | Financial assets
Set out below is an overview of financial assets, other than cash and short-term deposits, held by the Group as of December 31, 2023 and June 30, 2024:
Schedule of financial assets |  |  |  |  |  |  |  |  |
|  | December 31, |  |  | June 30, |
|  | 2023 |  |  | 2024 |  |  | 2024 |
|  | CNY |  |  | CNY |  |  | US$ |
|  | (Audited) |  |  | (Unaudited) |  |  | (Unaudited) |
Debt instruments at amortized cost: |  |  |  |  |  |  |  |  |  |  |  |
Financial assets included in other Receivables |  |  | 3 |  |  |  | 3 |  |  |  | — |
Total |  |  | 3 |  |  |  | 3 |  |  |  | — |
Total Current |  |  | 3 |  |  |  | 3 |  |  |  | — |
Total Non-current |  |  | — |  |  |  | — |  |  |  | — |
(b) |  | Financial liabilities
Set out below, is an overview of financial liabilities of the Group as of December 31, 2023 and June 30, 2024:
Schedule of financial liabilities |  |  |  |  |  |  |  |  |
|  | December 31, |  |  | June 30 |
|  | 2023 |  |  | 2024 |  |  | 2024 |
|  | CNY |  |  | CNY |  |  | US$ |
|  | (Audited) |  |  | (Unaudited) |  |  | (Unaudited) |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial liabilities (Note 16) |  |  | — |  |  |  | 4,419 |  |  |  | 608 |
Financial liabilities at amortized cost: |  |  |  |  |  |  |  |  |  |  |  |
Trade payables |  |  | 100 |  |  |  | 100 |  |  |  | 14 |
Financial liabilities in other payables and accruals |  |  | 7,864 |  |  |  | 2,677 |  |  |  | 368 |
Lease liabilities |  |  | 360 |  |  |  | 376 |  |  |  | 52 |
Due to related companies |  |  | 9,069 |  |  |  | 6,221 |  |  |  | 856 |
Due to the Shareholder |  |  | 85,673 |  |  |  | 77,317 |  |  |  | 10,639 |
Total |  |  | 103,066 |  |  |  | 91,110 |  |  |  | 12,537 |
Total current |  |  | 103,066 |  |  |  | 91,110 |  |  |  | 12,537 |
Total non-current |  |  | — |  |  |  | — |  |  |  | — |
(c) |  | Fair value
The following table provides the fair value measurement hierarchy of the Group's financial liabilities as at June 30, 2024:
Schedule of the fair value measurement hierarchy of the Group’s financial assets and financial liabilities |  |  |  |  |  |  |  |  |  |  |  |
|  | Quoted prices in active markets (Level 1) (Unaudited) |  |  | Significant observable inputs(Level 2) (Unaudited) |  |  | Significant unobservable inputs(Level 3) (Unaudited) |  |  | Total |
|  |  | CNY |  |  |  | CNY |  |  |  | CNY |  |  |  | CNY |
Financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial liabilities |  |  | — |  |  |  | 4,419 |  |  |  | — |  |  |  | 4,419 |
|  | Quoted prices in active markets (Level 1) (Unaudited) |  |  | Significant observable inputs(Level 2) (Unaudited) |  |  | Significant unobservable inputs(Level 3) (Unaudited) |  |  | Total |
|  |  | US$ |  |  |  | US$ |  |  |  | US$ |  |  |  | US$ |
Financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial liabilities |  |  | — |  |  |  | 608 |  |  |  | — |  |  |  | 608 |
There are no financial assets measured at fair value as of December 31, 2023 and June 30,2024. |
21. |  | FINANCIAL INSTRUMENTS
(a) |  | Financial assets
Set out below is an overview of financial assets, other than cash and short-term deposits, held by the Group as of December 31, 2022 and 2023:
Schedule of financial assets |  |  |  |  |  |  |  |  |
|  | December 31, |
|  | 2022 |  |  | 2023 |  |  | 2023 |
|  | CNY |  |  | CNY |  |  | US$ |
Debt instruments at amortized cost: |  |  |  |  |  |  |  |  |  |  |  |
Trade receivables: current |  |  | 46,760 |  |  |  | — |  |  |  | — |
Trade receivables: non-current |  |  | 10,520 |  |  |  | — |  |  |  | — |
Financial assets included in other receivables |  |  | 82,406 |  |  |  | 3 |  |  |  | — |
Financial assets at fair value through other comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |
Bills receivable |  |  | 8,500 |  |  |  | — |  |  |  | — |
Total |  |  | 148,186 |  |  |  | 3 |  |  |  | — |
Total current |  |  | 137,666 |  |  |  | 3 |  |  |  | — |
Total non-current |  |  | 10,520 |  |  |  | — |  |  |  | — |
(b) |  | Financial liabilities
Set out below is an overview of financial liabilities of the Group as of December 31, 2022 and 2023：
Schedule of financial liabilities |  |  |  |  |  |  |  |  |
|  | December 31, |  |  | December 31, |  |  | December 31, |
|  | 2022 |  |  | 2023 |  |  | 2023 |
|  |  | CNY |  |  |  | CNY |  |  |  | US$ |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial liabilities (i) |  |  | 824 |  |  |  | — |  |  |  | — |
Financial liabilities at amortized cost: |  |  |  |  |  |  |  |  |  |  |  |
Trade payables |  |  | 20,326 |  |  |  | 100 |  |  |  | 14 |
Financial liabilities in other payables and accruals |  |  | 6,749 |  |  |  | 7,864 |  |  |  | 1,111 |
Lease liabilities |  |  | 2,915 |  |  |  | 360 |  |  |  | 51 |
Due to related companies |  |  | 3,408 |  |  |  | 9,069 |  |  |  | 1,281 |
Due to the Shareholder |  |  | 7,153 |  |  |  | 85,673 |  |  |  | 12,103 |
Interest-bearing loans and borrowings |  |  | 74,000 |  |  |  | — |  |  |  | — |
Total |  |  | 115,375 |  |  |  | 103,066 |  |  |  | 14,560 |
Total current |  |  | 42,777 |  |  |  | 103,066 |  |  |  | 14,560 |
Total non-current |  |  | 72,598 |  |  |  | — |  |  |  | — |
(i) |  | This represents certain warrants issued to institutional investors on January 20, 2021, which was recognized as derivative financial liabilities (not designated as hedging instruments) with a fair value of CNY9,246 (US$1,427)* on the issue date as the investors have the right to exercise their warrants on a cashless basis. In accordance with IAS 32, a contract settled by a single net payment (generally referred to as net cash-settled or net equity-settled as the case may be) is a financial liability and not an equity instrument. The fair value gain of derivative financial liabilities for the years ended December 31, 2021, 2022 and 2023 was CNY7,467 and CNY1,007, CNY847 (US$120), respectively.
(c) |  | Fair value
Set out below is a comparison, by class, of the carrying amounts and fair values of the Group’s financial instruments, other than those with carrying amounts that are reasonable approximations of fair values:
Schedule of the carrying amounts and fair values of the Group’s financial instruments other than those with carrying amounts |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | December 31, |
|  | 2022 |  |  | 2023 |  |  | 2023 |
|  | CNY |  |  | CNY |  |  | US$ |
|  | Carrying amount |  |  | Fair value |  |  | Carrying amount |  |  | Fair value |  |  | Carrying amount |  |  | Fair value |
Financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest-bearing loans and borrowings |  |  | 74,000 |  |  |  | 77,636 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
The following table provides the fair value measurement hierarchy of the Group’s financial assets and financial liabilities as of December 31, 2022:
Schedule of the fair value measurement hierarchy of the Group’s financial assets and financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As of December 31, 2022 |  | Fair value measurement using |
|  | Quoted prices in active markets (Level 1) |  |  | Significant observable inputs (Level 2) |  |  | Significant unobservable inputs (Level 3) |  |  | Total |
|  | CNY |  |  | CNY |  |  | CNY |  |  | CNY |
Recurring fair value measurement: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Financial assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bills receivable |  |  | — |  |  |  | 8,500 |  |  |  | — |  |  |  | 8,500 |
Financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial liabilities |  |  | — |  |  |  | 824 |  |  |  | — |  |  |  | 824 |
There are no financial assets measured at fair value as of December 31, 2021 and 2023. Level 2: Bills receivable The fair value valuation of bills receivable is based on directly or indirectly observable inputs (such as recent bill discount rate) through valuation techniques. Derivative financial liabilities The fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximize the use of relevant observable inputs and minimize the use of unobservable inputs. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. There is no established public trading market for the warrants issued to investors on January 22, 2021. As of December 31, 2022, the Group measured the fair value of those warrants on a recurring basis using a binomial lattice pricing model with significant inputs including, among other relevant observable inputs, the underlying spot price of the Company’s common shares, exercise price, time to expiration, risk-free rate and equity volatility. During the years ended 2022 and 2023, there were no transfers of fair value measurements between Level 1 and Level 2 and no transfers into or out of Level 3 for both financial assets and liabilities.

X
- Definition The disclosure of financial instruments classified as held for trading. [Refer: Financial instruments, class [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsHeldForTradingExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NotesAndOtherExplanatoryInformationAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration